The prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational study

The prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational study

<p>Abstract</p> <p>Background</p> <p>Interferon beta (IFNβ) and glatiramer acetate (GA) are administered by subcutaneous (SC) or intramuscular (IM) injection. Patients with multiple sclerosis (MS) often report injection-site reactions (ISRs) as a reason for noncomplianc...

Full description

Bibliographic Details
Main Authors: Beer Karsten, Müller Martin, Hew-Winzeler Anna, Bont Adriano, Maire Philippe, You Xiaojun, Foulds Pamela, Mårlind Jessica, Curtius Daniela
Format: Article
Language:English
Published: BMC 2011-11-01
Series:BMC Neurology
Online Access:http://www.biomedcentral.com/1471-2377/11/144

Internet

http://www.biomedcentral.com/1471-2377/11/144

Similar Items